Medtronic PE ratio MDT
Share price divided by earnings per share over the last twelve months, since 2010.
- Today, Oct 23, 2026
- 23.4×
- 10-year median
- 28.2×
- Against its 10-year history
- 10th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 19.7× to 61.3×
- Peer median
- 30.9×
Medtronic's PE ratio is 23.4× as of Oct 23, 2026: a share price of $95.41 against $4.07 of earnings per share over the last twelve months.
That is below its ten-year median of 28.2×, lower than on 90% of days in the last ten years.
Over that time it ranged from 19.7× in Mar 2020 to 61.3× in Apr 2021.
The median for 7 medical device stocks of a similar size is 30.9×.
PE ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 23.4× | 20.6× | 27.8× |
| 2025 | 26.0× | 23.8× | 28.7× |
| 2024 | 24.7× | 24.7× | 32.1× |
| 2023 | 26.8× | 25.0× | 31.5× |
| 2022 | 24.1× | 20.4× | 31.3× |
| 2021 | 29.8× | 29.0× | 61.3× |
| 2020 | 44.7× | 19.7× | 44.7× |
| 2019 | 32.8× | 23.3× | 56.8× |
| 2018 | 54.1× | 21.5× | 59.1× |
| 2017 | 22.1× | 22.1× | 31.5× |
| 2016 | 23.7× | 23.7× | 50.4× |
| 2015 | 40.3× | 24.2× | 40.6× |
| 2014 | 25.5× | 14.9× | 26.0× |
| 2013 | 15.3× | 13.0× | 16.8× |
| 2012 | 12.4× | 11.0× | 13.0× |
| 2011 | 12.1× | 10.9× | 14.3× |
| 2010 | 12.8× | 10.6× | 13.6× |
Against its peers
Companies in Medical - Devices nearest Medtronic's size, closest first, today.
| Company | PE ratio |
|---|---|
| MDTMedtronic | 23.4× |
| SYKStryker | 31.8× |
| ABTAbbott Laboratories | 38.7× |
| BSXBoston Scientific | 18.5× |
| EWEdwards Lifesciences | 51.2× |
| GEHCGE HealthCare Technologies | 16.4× |
| DXCMDexCom | 30.9× |
| ZBHZimmer Biomet | 24.0× |
| Peer median | 30.9× |
Where Medtronic ranks
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Medtronic
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.